logo
Share SHARE
FONT-SIZE Plus   Neg

Sunpeaks Ventures Announces LoI To Export Clotamin To Top Russian Pharmacies

Sunpeaks Ventures, Inc. (SNPK.OB, SNPK.PK) and its wholly owned subsidiary Healthcare Distribution Specialists, LLC or "HDS" announce that HDS has signed a Letter of Intent with PharmaLife for placement of Clotamin with leading pharmacies in the Russian Federation.

The Letter of Intent outlines the terms and conditions of a proposed transaction that could see Clotamin distributed by several pharmacy and retail chains in the Russian Federation, including product placement with leading wholesalers Imperia-Pharma, the Dr. Stoletov pharmacy chain (414 locations), and other small retail pharmacies associated with Imperia-Pharma.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Carnival Corporation & plc (CCL, CCL.L, CUK) reported a profit for the third-quarter that increased 17 percent from the prior year. The company said it is well on track to deliver nearly 25 percent earnings growth in 2016. It raised adjusted earnings per share guidance for 2016. Samsung Electronics Co., Ltd. said it will delay restarting the sale of its Galaxy Note 7 phone in South Korea. The decision is said to reflect the requirement of more time for the global recall as dozens of devices caught fire. Shares of Marinus Pharmaceuticals Inc. (MRNS) have gained over 35% in the last seven trading days in the run-up to the exploratory phase II study results of Ganaxolone, scheduled for this month.
comments powered by Disqus
Follow RTT